Martin Hoenigl, ECCMID 2021: Ibrexafungerp for Patients with Refractory Fungal Diseases
We were delighted to meet with Martin Hoenigl (University of California San Diego, San Diego, USA & Medical University of Graz, Graz, Austria) to discuss the interim analysis from a phase 3 study, investigating ibrexafungerp in patients with refractory fungal diseases. The abstract entitled: ‘Outcomes of oral ibrexafungerp in 33 patients with refractory fungal diseases, […]
Christina Muzny: Secnidazole for the Treatment of Trichomoniasis and Bacterial Vaginosis
It was a great pleasure to meet with Dr Christina Muzny (University of Alabama at Birmingham, Birmingham, AL, USA) to discuss the findings from the recent Phase III clinical study that has led to the approval of secnidazole for the treatment of trichomoniasis and bacterial vaginosis. Questions: What are the unmet needs in the treatment […]
Jeffrey Strich: Phase 2 Trial Results Investigating Fostamatinib for the treatment of COVID-19
It was a great pleasure to meet with Jeffrey Strich (National Institutes of Health Clinical Center, Bethesda, MD, USA) to discuss the findings from a recent phase 2 study investigating fostamatinib for the treatment of hospitalized adults with COVID-19. Useful Resources: Published data available here: Fostamatinib for the treatment of hospitalized adults with COVID-19 A […]
Evangelos Giamarellos-Bourboulis: Phase 3 SAVE-MORE Study Results Investigating Anakinra in the Treatment of Severe COVID-19
It was a great pleasure to meet with Prof. Evangelos Giamarellos-Bourboulis (Attikon University Hospital, Athens, Greece) to discuss phase 3 SAVE-MORE study assessing the effect of anakinra for the treatment of patients with COVID-19 pneumonia. Useful Resources: Publication available to access here: https://www.nature.com/articles/s41591-021-01499-z Questions: Could you give us a brief overview of the role of […]
Want To Know More About Our Journal?
Taking a balanced and practical view of the current clinical landscape in Infectious Diseases is at the heart of touchINFECTIOUS DISEASES and the journal we produce.
touchREVIEWS in Infectious Diseases is an international, free-to-access, peer reviewed journal that aims to provide balanced and objective articles relevant to the day-to-day clinical setting.
Journal articles and more to your inbox
Get the latest clinical insights from touchINFECTIOUS DISEASESSign me up!